We are live on ! Find out more
JGUA

John G. Ullman & Associates Portfolio holdings

AUM $754M
1-Year Est. Return 60.05%
This Fund
S&P 500
This Quarter Est. Return
+8.25%
1 Year Est. Return
+60.05%
3 Year Est. Return
+108.28%
5 Year Est. Return
+118.76%
10 Year Est. Return
+308.24%
AUM
$652M
AUM Growth
+$21.4M
Cap. Flow
-$20M
Cap. Flow %
-3.06%
Top 10 Hldgs %
31.53%
Holding
180
New
11
Increased
35
Reduced
93
Closed
6

Top Buys

Rank Stock Value
1
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$3.69M
2
TMP icon
Tompkins Financial
TMP
+$3.57M
3
NTES icon
NetEase
NTES
+$1.96M
4
AMT icon
American Tower
AMT
+$1.8M
5
INST
Instructure Holdings, Inc.
INST
+$1.65M

Top Sells

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$7.15M
2
EMR icon
Emerson Electric
EMR
+$6.15M
3
EQNR icon
Equinor
EQNR
+$4.39M
4
NRG icon
NRG Energy
NRG
+$2.72M
5
ES icon
Eversource Energy
ES
+$2.55M

Sector Composition

Rank Sector Weight
1 Technology 31.68%
2 Healthcare 17.44%
3 Industrials 15.98%
4 Utilities 9.18%
5 Energy 5.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MCO icon
51
Moody's
MCO
$82.2B
$4.27M 0.65%
10,857
-350
-3% -$135K
ZBH icon
52
Zimmer Biomet
ZBH
$18.3B
$4.23M 0.65%
32,080
-584
-2% -$73K
VOO icon
53
Vanguard S&P 500 ETF
VOO
$1.01T
$4.11M 0.63%
8,552
-227
-3% -$104K
IDA icon
54
Idacorp
IDA
$8.2B
$3.81M 0.58%
40,993
-525
-1% -$48.1K
GSK icon
55
GSK
GSK
$106B
$3.71M 0.57%
86,460
-2,280
-3% -$94K
JAZZ icon
56
Jazz Pharmaceuticals
JAZZ
$16.7B
$3.63M 0.56%
+30,150
New +$3.69M
STT icon
57
State Street
STT
$51B
$3.52M 0.54%
45,510
-1,300
-3% -$96.4K
LITE icon
58
Lumentum
LITE
$69.7B
$3.5M 0.54%
73,973
+15,282
+26% +$777K
ABT icon
59
Abbott
ABT
$186B
$3.49M 0.54%
30,709
-265
-0.9% -$30.4K
INST
60
DELISTED
Instructure Holdings, Inc.
INST
$3.39M 0.52%
158,476
+70,012
+79% +$1.65M
PYPL icon
61
PayPal
PYPL
$50.5B
$3.2M 0.49%
47,735
+8,450
+22% +$519K
AAPL icon
62
Apple
AAPL
$4.56T
$3.15M 0.48%
18,343
+200
+1% +$36.4K
BKH icon
63
Black Hills Corp
BKH
$5.67B
$3.1M 0.48%
56,842
+9,962
+21% +$522K
GE icon
64
GE Aerospace
GE
$386B
$3.04M 0.47%
21,672
-10,831
-33% -$1.28M
ARCB icon
65
ArcBest
ARCB
$3.08B
$3.02M 0.46%
21,225
-525
-2% -$68.8K
VNM icon
66
VanEck Vietnam ETF
VNM
$504M
$3.01M 0.46%
216,900
+20,600
+10% +$272K
AMGN icon
67
Amgen
AMGN
$221B
$2.98M 0.46%
10,464
-350
-3% -$102K
VNT icon
68
Vontier
VNT
$4.93B
$2.95M 0.45%
65,097
-800
-1% -$31.2K
EA
69
DELISTED
Electronic Arts
EA
$2.92M 0.45%
22,000
-50
-0.2% -$6.86K
LLY icon
70
Eli Lilly
LLY
$1.05T
$2.77M 0.42%
3,558
-440
-11% -$313K
PEG icon
71
Public Service Enterprise Group
PEG
$37.7B
$2.75M 0.42%
41,194
-200
-0.5% -$12.2K
A icon
72
Agilent Technologies
A
$41B
$2.73M 0.42%
18,776
-200
-1% -$27.4K
ORCL icon
73
Oracle
ORCL
$419B
$2.72M 0.42%
21,630
-100
-0.5% -$11.4K
BAX icon
74
Baxter International
BAX
$14.3B
$2.7M 0.41%
63,107
+8,900
+16% +$362K
CHWY icon
75
Chewy
CHWY
$9.68B
$2.61M 0.4%
164,189
+59,300
+57% +$1.07M
1 2
3
4 5

Similar funds

HCM
HMI Capital Management San Francisco, California $754M AUM 23.78% 1-Year Est. Return
FSCM
Front Street Capital Management Missoula, Montana $754M AUM 73.72% 1-Year Est. Return
RMC
Resources Management Corp West Hartford, Connecticut $753M AUM 20.77% 1-Year Est. Return
BEC
Blue Edge Capital Richmond, Virginia $753M AUM 18.89% 1-Year Est. Return
GFM
GCQ Funds Management Sydney, Australia $753M AUM 2.76% 1-Year Est. Return
TPW
Talon Private Wealth The Villages, Florida $753M AUM
MWA
Meridian Wealth Advisors Austin, Texas $756M AUM 21.36% 1-Year Est. Return
TCMI
Technology Crossover Management IX Menlo Park, California $752M AUM 25.7% 1-Year Est. Return

John G. Ullman & Associates's Q1 2024 Portfolio in Review

As of Q1 2024, John G. Ullman & Associates held 180 positions worth $652M, up 3.4% from $630M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

John G. Ullman & Associates withdrew a net $20M in Q1 2024, closing 6 positions and reducing 93 holdings. Its most notable exit was JPMorgan Chase, an estimated $7.15M position sold in full.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, John G. Ullman & Associates opened a new position in Jazz Pharmaceuticals worth $3.63M.

  • John G. Ullman & Associates's largest Q1 2024 buy was Jazz Pharmaceuticals: 30,150 shares worth $3.63M.
  • John G. Ullman & Associates added most to Tompkins Financial in Q1 2024, an estimated $3.57M increase.
  • John G. Ullman & Associates's biggest Q1 2024 reduction was Emerson Electric, cutting an estimated $6.15M.
  • John G. Ullman & Associates fully exited JPMorgan Chase in Q1 2024, selling an estimated $7.15M.
  • John G. Ullman & Associates's ten largest holdings make up 32% of its $652M portfolio in Q1 2024.
  • John G. Ullman & Associates opened 11 new positions and closed 6 in Q1 2024.
  • John G. Ullman & Associates's portfolio value rose 3.4% quarter-over-quarter to $652M.

Based on John G. Ullman & Associates's 13F filing for Q1 2024, filed 6 May 2024.